As a major contributor of knowledge, Nigeria could make giant strides in nanotechnology – which in turn could help various industries blossom.
Academic rigour, journalistic flair
Articles on Science and innovation for development
Displaying 21 - 40 of 220 articles
The African BioGenome Project is a pan-African project that seeks to sequence Africa’s endemic and indigenous plants and animals.
There remains a crucial need for animal models to understand health and disease and to develop medicines.
In 2020 TB case detection fell by almost 20% and mortality rose for the first time in a decade. These setbacks are directly attributable to the COVID-19 pandemic.
With the manufacturing capacity and access to relevant technology, African countries can reduce their dependency on international manufacturers for vaccines.
Saponins from plants can destroy viruses and other microorganisms in the same way commercial soaps and detergents do.
Young academies, which generally represent early career scientists, fared far better than their senior counterparts - a promising sign for the future.
As a disease progresses, so too must the underlying data and reporting improve to manage the progression of the outbreak.
To attain a new health order, African governments need to bolster investment in research and development, innovation and manufacturing of health tools.
At this stage, we cannot say anything about the severity of cases with Omicron - either in primary or reinfections.
To be effective, vaccine formulas need to cover all emergent strains. But there are still plenty of unknowns.
Manufacturing is just one part of the vaccine ecosystem. It’s the health system that delivers vaccines and people must be willing to take them.
The need of the moment is for low- and middle-income countries to improve their own manufacturing capabilities.
Afrigen will be a technology transfer and training hub: it shares technology and develops skills specifically around how to produce a safe, effective and affordable mRNA vaccine.
Continuous growth of energy production and consumption, even from low carbon energy sources, could create more problems than solutions.
The creation of a Research Excellence Barometer for Africa would contribute to retaining talent and expertise and ensure that Africans benefited from their own research efforts.
This challenges the current assumption that coughing is the primary driver of TB transmission.
For the first time, the drug substance, or active ingredient for a COVID-19 vaccine - in this case mRNA - will be manufactured on the continent.
New technologies can help reduce the cost of producing maps that warn where floods might happen.
Pre-COVID-19 dentists wore some sort of respiratory protection like examination masks, surgical masks or respirators. COVID-19 has elevated the number of personal protective equipment needed.
Job Board
-
Associate Professor, Occupational Therapy
-
GRAINS RESEARCH AND DEVELOPMENT CORPORATION CHAIRPERSON
-
Technical Skills Laboratory Officer
-
Faculty of Law - Academic Appointment Opportunities
-
Audience Development Coordinator (fixed-term maternity cover)
Top contributors
-
Researcher, Lecturer, Attorney, University of KwaZulu-Natal
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Organic Chemistry, Neville Isdell Chair in African-centric Drug Discovery & Development, and Director of the Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town
-
Professor of the Practice of International Development, Harvard Kennedy School
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Head of the Centre of Excellence for Biomedical TB Research, University of the Witwatersrand
-
Tutorial Fellow, School of Medicine, University of Nairobi, University of Nairobi
-
Associate Professor at the University of Pretoria and Co-ordinator of the South African SDG Hub, University of Pretoria
-
Post Doctoral Fellow, University of KwaZulu-Natal
-
Professor in Biochemistry, Genetics and Microbiology, and Professor at Future Africa, University of Pretoria, University of Pretoria
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Director, Institute for Cellular and Molecular Medicine & SAMRC Extramural Unit for Stem Cell Research & Therapy, University of Pretoria
-
Director of Science, Ifakara Health Institute
-
Head of the Division of Pulmonology, University of Cape Town
-
Fellow, Nigerian Academy of Science
